Biopharmaceutical company Pfizer announced today that a Phase 2/3 trial revealed that the COVID-19 vaccine was safe resulted in a “robust” antibody response in children ages 5 to 11, according to CNN and their company press release. Pfizer said in the release that it will submit to the US Food and Drug Administration for emergency … Continued
The post COVID-19 vaccine trial for 5 to 11 year olds deemed safe appeared first on New Pittsburgh Courier.
